Explore more Categories
Artificial Intelligence involves the science and engineering of developing intelligent machines
The manufacturing world is at a cusp of a new revolution that will redefine conventional business models
IoT will have a major impact on businesses and consumers in the future
The world is creating 2.5 exabytes of data daily
Our research seeks to connect-the-dots across multiple trends
Personal Robots are Set to Be a $19 Billion Market
Strategic Analysis of BREXIT and its Implications to Industries, Economies and Societies
Time for a Digital Revolution in the Women’s Health Market
iFrost is a digital platform for interactive and dynamic reporting of data.
The TOEs are a great source of information which gives corporates critical information on companies to action for their strategic investments either as an open source platform or to collaborate and to develop successful products
Low Diagnosis Rate of 26% Presents Opportunities to Unlock and Tap in to a Large Market
save 15 %
* Required Fields
Pay by invoice
Diabetes is a growing concern, with more than 425 million people suffering the world over. Indonesia is no exception. It has high prevalence, of about 7% or an estimated 10.48 million diabetics in the country in 2018. Unfortunately, only about 26% of this population is actually diagnosed, meaning over two-thirds of those diabetics are diagnosed only at later stages, often after complications arise; complications which decrease quality of life and also increases the cost of care. Indonesia being predominantly uninsured or not offering coverage for diabetes management devices also means that glucose levels tend to be irregularly monitored. This results in even the diagnosed population developing health complications due to the condition. The potential for the market in Indonesia, and Asia-Pacific countries in general is huge, but is hampered by access and affordability issues. For any company to target these markets, it is crucial to understand the current competitive landscape, reimbursement and regulatory policies, and also the distribution structure of the market to best understand their opportunity and go-to-market strategy.There are four types of medical devices that are crucial for diabetics: self-monitoring of blood glucose (SMBG) and the professional point-of-care testing (POCT); continuous glucose monitoring (CGM); insulin pens; and insulin pumps. Broadly, these can be classified under monitoring (SMBG, POCT and CGM), and management (insulin pens and insulin pumps). Most of the Asia-Pacific region see these devices being imported, provided by mostly the multinational majors of diabetes, and in case of SMBG products, even some low-cost devices from China & Taiwan. Some of the major names in the space for SMBG and POCT testing are Roche, Abbott, LifeScan and Ascensia Diabetes Care. In the case of CGM, Medtronic dominates the Asia-Pacific region, with the global majors of Dexcom and Abbott not having ventured into this region, as yet. The insulin pen segment is dominated by pharmaceutical companies: Novo Nordisk, Sanofi, and Eli Lilly. Some other players may also be present, depending on the country in question (for e.g., Biocon from India). Insulin Pumps segment too is dominated by Medtronic, though the South Korean manufacturer SOOIL Development is present in some countries in the Asia-Pacific region. Medtronic also supplies basic and/or advanced versions of its pumps, depending on the country in question. Other western players such as Insulet have not entered this market yet. This study provides an in-depth view for each of the 4 segments of SMBG and POCT, CGM, insulin pens and insulin pumps, with drivers, restraints, market revenue forecasts, average selling prices of products and consumables, market shares of the top players, their market strategies, and route to market. In addition, it provides a country-level overview of public health policies for diabetics, reimbursement and regulatory insights, as well as distribution insights with key distributors highlighted, and also growth opportunities for the diabetes market in the country.Author: Siddharth Shah
Internet of Things (IoT) Based Technologies and Patient Preference to Drive Growth of the Global Home Healthcare Solutions Market, 2025
Artificial Intelligence and Robotic Innovations Transforming the Global Endoscopy Devices Market
Increasing Demand for Value-based Care and Acute Shortage of ICU Staff to Drive Growth of the US & EU-5 Virtual Critical Care Solutions Market, 2025
Frost Radar™: Global Endoscopy Market, 2020
Thai Diabetes Devices Market, Forecast to 2023
Malaysian Diabetes Devices Market, Forecast to 2023
Philippine Diabetes Devices Market, Forecast to 2023
Emerging Sensor Technologies Transforming Medical Diagnostics
Innovations in Transdermal Drug Delivery
Global Healthcare Service as Product Solutions, 2016
augmented reality market
consumer drone market
wireless charging market
wound care market
biometric authentication market
Don't have an account? Create One!
Enter your Email Address here to receive a link to change password.
If you are an existing frost.com user, please register using the same email for seamless access
Already have an account? Login!
Use your Linkedin account to login or register within our store.You're just one click away.